Recent

% | $
Quotes you view appear here for quick access.

Hyperion Therapeutics, Inc. (HPTX) Message Board

  • rrtzrealmd rrtzrealmd Mar 20, 2013 2:17 PM Flag

    Gotta hate them donut holes...

    ...from HPTX's prospectus:

    Within the Medicare program, as a self-administered drug, Ravicti would be, and BUPHENYL is, reimbursed under the expanded prescription drug benefit, known as Medicare Part D...Historically, Part D beneficiaries have been exposed to significant out-of-pocket costs after they surpass an annual coverage limit and until they reach a catastrophic coverage threshold. However, changes made by recent legislation will reduce this patient coverage gap, known as the donut hole, by transitioning patient responsibility in that coverage range from 100% in 2010 to only 25% in 2020. To help achieve this reduction, beginning in 2011, pharmaceutical manufacturers are required to pay quarterly discounts of 50% off the negotiated price of branded drugs issued to Medicare Part D patients in the donut hole."

    ...oh, man!...a 50% haircut?...gee, that's gotta put a crimp in the old profit margin!...add that to the 23.1%discount Medicaid gets and pretty soon there ain't goin' be no profit margin!...HAW, HAW, HAW!!!...

    Sentiment: Strong Sell

 
HPTX
42.74-0.82(-1.88%)Mar 27 4:00 PMEDT